Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridization.

Cancer genetics and cytogenetics - 15 Apr 2005

Slovak Marilyn L, Bedell Victoria, Pagel Kristen, Chang Karen L, Smith David, Somlo George

Abstract excerpt

Standard fluorescence in situ hybridization (FISH) easily detects nonrandom karyotypic abnormalities in multiple myeloma (MM) at disease presentation, when tumor burden is high. In contrast, the detection of residual MM using the standard 200 unselected nonmitotic nuclei FISH approach correlates poorly with residual disease detected by morphology, flow cytometry, immunohistochemistry, or reverse-transcription...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosomes, Human, Pair 13
Share to Chromosomes, Human, Pair 17

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clone Cells

Share to Cytogenetic Analysis

Share to Immunoglobulin Heavy Chains

Share to Multiple Myeloma

Share to Plasma Cells

Share to Ploidies

Source

Identifiers

PMID: 15796956
DOI: 10.1016/j.cancergencyto.2005.01.006

Genes

IGH

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridization.PMID 15796956Read ↗

Detection of Genomic Abnormalities in Multiple MyelomaSemantic proximity Read ↗

Plasma Cell Enrichment and New Genomic Approaches in Multiple Myeloma: A Scoping ReviewSemantic proximity Read ↗

Recent advances in cytogenetic characterization of multiple myelomaSemantic proximity Read ↗

Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myelomaSemantic proximity Read ↗

Guidelines for the testing and reporting of cytogenetic results for risk stratification of multiple myeloma: a report of the Cancer Genomics Consortium Plasma Cell Neoplasm Working GroupSemantic proximity Read ↗

Clinicopathological features of plasmablastic multiple myeloma: a population‐based cohortSemantic proximity Read ↗

Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantationSemantic proximity Read ↗

Monitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cellsSemantic proximity Read ↗

Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 studySemantic proximity Read ↗

High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISHSemantic proximity Read ↗

Sensitivity, specificity, and accuracy of molecular profiling on circulating cell-free DNA in refractory or relapsed multiple myeloma patients, results of MM-EP1 study.Semantic proximity Read ↗

Noninvasive Molecular Monitoring in Multiple Myeloma Patients Using Cell-Free Tumor DNASemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.